Simplex Trading’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Other funds holding BCYC
RS
PWMAG
Simplex Trading's BCYC Position: Q3 2026 in Review
Simplex Trading increased its Bicycle Therapeutics (BCYC) stake by 33% in Q3 2026, buying an estimated $47.3K and bringing the position to 46,923 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #4792.
Simplex Trading first reported a position in BCYC in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.7M in Q2 2023. 25 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.
- Simplex Trading held 46,923 shares of Bicycle Therapeutics worth $173K as of Q3 2026.
- Simplex Trading bought 11,691 Bicycle Therapeutics shares in Q3 2026, an estimated $47.3K.
- Bicycle Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #4792 holding.
- Simplex Trading first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 14 quarters since.
- Simplex Trading's Bicycle Therapeutics position peaked at $1.7M in Q2 2023.
- 25 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.